Seres Therapeutics receives $50 million from Nestlé Health Science
CAMBRIDGE, Mass. - Seres Therapeutics, Inc. (NASDAQ:MCRB), a clinical-stage biotherapeutic company with a market ...
Seres Receives $50 Mln Installment Payment Towards Sale Of VOWST Business To Nestle Health Science
Seres Therapeutics, Inc. (MCRB), a live biotherapeutics company, Thursday said that it has received a $50 million installment payment ...
Sell Rating for Nestlé SA: Concerns Over Operating Margins, Pricing Challenges, and Growth Prospects
Jefferies analyst David Hayes downgraded the rating on Nestlé SA (NSRGF – Research Report) to a Sell today, setting a price target of ...
Dairy Reporter1mon
Nestlé deepens exploration of bioactives to support muscle health and longevity
Recent studies point to the benefits of a range of bioactives, including nicotinamide, pyridoxine, oleuropein and ...
The Hill on MSN15d
Changing alcohol labels could take ‘decades’: Dr. Marion Nestle
It’s a move that Dr. Marion Nestle, a professor of nutrition, food studies and public health at New York University, called ...
FoodBev Media6d
Nestlé launches GLP-1 friendly high-protein frozen pizzas with Vital Pursuit Max Pro line
This product aligns with a growing consumer trend focused on high-protein foods, particularly among those following GLP-1 ...
Managingip.com10d
The IP Lounge: Nestlé’s Myrtha Hurtado Rivas on wellbeing focus
One of Managing IP’s most influential people in IP for 2024, Hurtado Rivas discusses mental health in the profession, the ...